Two randomized trials in China find that intra-arterial thrombolysis with urokinase or tenecteplase does not significantly ...
EPICC HPV Elimination Partnership being supplied PROCEEDxFLOQ QAPs to Support Test Accuracy MISSISSAUGA, Ontario and ...
Refining its techniques and technology over the last three decades, Boster Biological Technology continues to build on its reputation as a trusted partner for researchers worldwide, offering a wide ...
Intra-arterial Thrombolysis Fails to Improve Stroke Outcomes Two randomized trials in China find that intra-arterial thrombolysis with urokinase or tenecteplase does not significantly improve ...
可溶性尿激酶型纤溶酶原激活剂受体(Soluble urokinase plasminogen activator receptor,SuPAR)是一种炎症和免疫激活的生物标志物,已被证实与老年人多种疾病的死亡率相关。其在非心脏手术术前评估中的预后价值颇具前景。然而,截至目前,尚无针对接受髋部骨折手术 ...
After hours: March 14 at 4:05:08 p.m. EDT Loading Chart for MNPR ...
The bioengineered protein drugs market is experiencing a paradigm shift, with pharmaceutical and biotech companies leveraging advanced biopharmaceuti ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果